Cargando…
EFFICACY OF SUPPLEMENTAL HEMOADSORPTION THERAPY ON SEVERE AND CRITICAL PATIENTS WITH COVID-19: AN EVIDENCE-BASED ANALYSIS
Background: The COVID-19 pandemic has posed a disproportionately high threat to the global health system and social stability. COVID-19 damage can lead to hyperinflammation and tissue damage due to a “cytokine storm,” which in turn contributes to an increase in the mortality rate. Extracorporeal hem...
Autores principales: | He, Junbing, Lin, Yao, Cai, Weiming, Lin, Yingying, Qin, Wanbing, Shao, Yiming, Liu, Qinghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510838/ https://www.ncbi.nlm.nih.gov/pubmed/37548606 http://dx.doi.org/10.1097/SHK.0000000000002189 |
Ejemplares similares
-
Hemoadsorption therapy in the critically ill: solid base but clinical haze
por: Honoré, Patrick M., et al.
Publicado: (2019) -
Efficacy and safety of nafamostat mesilate anticoagulation in blood purification treatment of critically ill patients: a systematic review and meta-analysis
por: Lin, Yao, et al.
Publicado: (2022) -
Hemoadsorption efficacy for uncomplicated high-risk cardiac surgery
por: Redant, Sébastien, et al.
Publicado: (2019) -
Hemoadsorption in Critical Care – It is a Useful or a Harmful Technique?
por: Kovacs, Judit
Publicado: (2020) -
Hemoadsorption in the critically ill—Final results of the International CytoSorb Registry
por: Hawchar, Fatime, et al.
Publicado: (2022)